Share Price and Basic Stock Data
Last Updated: January 7, 2026, 11:38 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Daikaffil Chemicals India Ltd operates in the dyes and pigments industry, with its stock currently priced at ₹74.5 and a market capitalization of ₹44.7 Cr. The company has experienced significant revenue fluctuations, with sales reported at ₹0.64 Cr for FY 2023, down from ₹8.16 Cr in FY 2022. The trailing twelve months (TTM) revenue stood at ₹17.42 Cr. Notably, sales have shown minimal activity in recent quarters, particularly from September 2022 to September 2023, where figures consistently indicated negligible revenue. However, projections for FY 2025 show a rebound, with reported sales expected to reach ₹7.50 Cr. The company’s operating profit margin (OPM) has been negative, recorded at -21.03%, indicating operational challenges. The significant drop in sales and the negative profitability metrics suggest that Daikaffil may be struggling to maintain market presence amidst competitive pressures in the sector.
Profitability and Efficiency Metrics
Daikaffil’s profitability metrics reveal a challenging landscape. The company reported a net profit of -₹2.41 Cr for FY 2023, an alarming decline from -₹2.50 Cr in FY 2022. The return on equity (ROE) and return on capital employed (ROCE) both stood at 18.6%, indicating some efficiency in generating returns relative to shareholder equity despite the net losses. However, the operating profit margin has been consistently negative, with no positive operating profit reported from March 2023 to March 2025, reflecting ongoing operational inefficiencies. The interest coverage ratio (ICR) is exceptionally high at 188.00x, indicating that the company has ample capacity to cover its interest expenses, although it has no reported borrowings. This high ICR suggests a strong liquidity position, but the persistent losses undermine overall profitability.
Balance Sheet Strength and Financial Ratios
On the balance sheet front, Daikaffil Chemicals exhibits a solid structure with total borrowings reported at ₹0.00 Cr, indicating no reliance on debt financing. The company’s reserves have dwindled to ₹1.90 Cr as of September 2025, down from ₹19.54 Cr in FY 2018, illustrating a significant erosion of retained earnings over the years. The price-to-book value (P/BV) ratio stands at 1.34x, suggesting that the stock is valued slightly above its book value, which is relatively typical for companies in this sector. The cash conversion cycle (CCC) is reported at 215.26 days, indicating potential inefficiencies in managing inventory and receivables. Overall, while the balance sheet appears strong in terms of debt management, the declining reserves and high CCC raise concerns about operational effectiveness and financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Daikaffil Chemicals reflects a significant concentration of ownership, with promoters holding 52.64% of the equity as of September 2025. This level of promoter holding can be indicative of strong control over the company, which may instill confidence among investors. However, the public shareholding has decreased from 68.82% in December 2022 to 47.34% in September 2025, suggesting a potential decline in investor confidence or a strategic shift by the promoters to consolidate ownership. The total number of shareholders declined from 3,735 in December 2022 to 3,134 in September 2025, further indicating a reduced retail investor interest. The absence of foreign institutional investments (FIIs) and domestic institutional investments (DIIs) could also be a concern, reflecting a lack of broader market confidence in the company’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, Daikaffil Chemicals faces several risks alongside potential recovery opportunities. The significant decline in sales and persistent operational losses present immediate challenges. However, the company’s high interest coverage ratio and the absence of borrowings provide a buffer against financial distress. A rebound in sales to ₹7.50 Cr in FY 2025 could signal a turnaround if operational efficiencies are improved. Conversely, sustained negative profitability and declining reserves may restrict growth and investor interest. The company must focus on enhancing operational efficiency and addressing its negative margins to regain market confidence. In a scenario where operational improvements coincide with a recovery in demand for dyes and pigments, Daikaffil could leverage its strong balance sheet to reposition itself favorably within the industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 36.0 Cr. | 119 | 190/68.5 | 19.8 | 162 | 0.84 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 45.6 Cr. | 76.0 | 281/68.5 | 13.2 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 814 Cr. | 658 | 1,148/452 | 21.0 | 91.7 | 0.15 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,658 Cr. | 332 | 570/272 | 34.4 | 62.2 | 1.50 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 60.1 Cr. | 53.5 | 67.1/38.0 | 37.7 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,332.15 Cr | 296.99 | 92.81 | 186.93 | 0.40% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 3.50 | 4.00 | 3.88 | 6.04 |
| Expenses | 0.43 | 0.43 | 0.40 | 0.40 | 0.29 | 0.25 | 1.31 | 0.44 | 0.90 | 3.55 | 4.41 | 3.36 | 7.31 |
| Operating Profit | -0.42 | -0.43 | -0.40 | -0.40 | -0.29 | -0.25 | -1.31 | -0.44 | -0.90 | -0.05 | -0.41 | 0.52 | -1.27 |
| OPM % | -4,200.00% | -1.43% | -10.25% | 13.40% | -21.03% | ||||||||
| Other Income | 0.13 | 0.10 | 0.11 | 0.17 | 0.23 | 0.15 | 0.16 | 0.10 | 0.09 | 0.07 | 0.21 | 0.01 | 0.01 |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.01 | -0.00 |
| Depreciation | 0.18 | 0.18 | 0.55 | 0.23 | 0.22 | 0.22 | -0.32 | 0.07 | 0.06 | 0.06 | 0.08 | 0.10 | 0.08 |
| Profit before tax | -0.47 | -0.51 | -0.84 | -0.46 | -0.28 | -0.32 | -0.83 | -0.41 | -0.87 | -0.04 | -0.28 | 0.42 | -1.34 |
| Tax % | 2.13% | -9.80% | -26.19% | -4.35% | -14.29% | -12.50% | 13.25% | -26.83% | -33.33% | 775.00% | 25.00% | -0.00% | -0.00% |
| Net Profit | -0.48 | -0.47 | -0.62 | -0.43 | -0.24 | -0.28 | -0.95 | -0.30 | -0.58 | -0.36 | -0.35 | 0.42 | -1.34 |
| EPS in Rs | -0.80 | -0.78 | -1.03 | -0.72 | -0.40 | -0.47 | -1.58 | -0.50 | -0.97 | -0.60 | -0.58 | 0.70 | -2.23 |
Last Updated: December 27, 2025, 9:34 am
Below is a detailed analysis of the quarterly data for Daikaffil Chemicals India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 6.04 Cr.. The value appears strong and on an upward trend. It has increased from 3.88 Cr. (Jun 2025) to 6.04 Cr., marking an increase of 2.16 Cr..
- For Expenses, as of Sep 2025, the value is 7.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.36 Cr. (Jun 2025) to 7.31 Cr., marking an increase of 3.95 Cr..
- For Operating Profit, as of Sep 2025, the value is -1.27 Cr.. The value appears to be declining and may need further review. It has decreased from 0.52 Cr. (Jun 2025) to -1.27 Cr., marking a decrease of 1.79 Cr..
- For OPM %, as of Sep 2025, the value is -21.03%. The value appears to be declining and may need further review. It has decreased from 13.40% (Jun 2025) to -21.03%, marking a decrease of 34.43%.
- For Other Income, as of Sep 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.01 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 0.08 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.10 Cr. (Jun 2025) to 0.08 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is -1.34 Cr.. The value appears to be declining and may need further review. It has decreased from 0.42 Cr. (Jun 2025) to -1.34 Cr., marking a decrease of 1.76 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -1.34 Cr.. The value appears to be declining and may need further review. It has decreased from 0.42 Cr. (Jun 2025) to -1.34 Cr., marking a decrease of 1.76 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.23. The value appears to be declining and may need further review. It has decreased from 0.70 (Jun 2025) to -2.23, marking a decrease of 2.93.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:53 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.28 | 34.35 | 27.41 | 26.44 | 22.82 | 16.84 | 15.72 | 11.40 | 8.16 | 0.64 | 0.00 | 7.50 | 17.42 |
| Expenses | 30.31 | 31.36 | 24.24 | 21.77 | 19.53 | 15.04 | 13.88 | 11.23 | 10.20 | 2.55 | 2.25 | 9.29 | 18.63 |
| Operating Profit | 2.97 | 2.99 | 3.17 | 4.67 | 3.29 | 1.80 | 1.84 | 0.17 | -2.04 | -1.91 | -2.25 | -1.79 | -1.21 |
| OPM % | 8.92% | 8.70% | 11.57% | 17.66% | 14.42% | 10.69% | 11.70% | 1.49% | -25.00% | -298.44% | -23.87% | -6.95% | |
| Other Income | 0.29 | -0.16 | 0.55 | 0.55 | 0.85 | 0.42 | 0.85 | 0.55 | 0.47 | 0.47 | 0.71 | 0.47 | 0.30 |
| Interest | 0.36 | 0.26 | 0.14 | 0.07 | 0.05 | 0.03 | 0.07 | 0.05 | 0.03 | 0.01 | 0.00 | 0.01 | 0.01 |
| Depreciation | 0.61 | 0.42 | 0.40 | 1.48 | 0.97 | 0.96 | 1.12 | 1.12 | 1.13 | 1.21 | 0.35 | 0.27 | 0.32 |
| Profit before tax | 2.29 | 2.15 | 3.18 | 3.67 | 3.12 | 1.23 | 1.50 | -0.45 | -2.73 | -2.66 | -1.89 | -1.60 | -1.24 |
| Tax % | 37.55% | 27.91% | 33.96% | 33.51% | 23.40% | 29.27% | 28.00% | -11.11% | -8.42% | -9.77% | 0.53% | -0.62% | |
| Net Profit | 1.44 | 1.55 | 2.10 | 2.44 | 2.40 | 0.86 | 1.08 | -0.41 | -2.50 | -2.41 | -1.90 | -1.59 | -1.63 |
| EPS in Rs | 2.40 | 2.58 | 3.50 | 4.07 | 4.00 | 1.43 | 1.80 | -0.68 | -4.17 | -4.02 | -3.17 | -2.65 | -2.71 |
| Dividend Payout % | 33.33% | 30.97% | 28.57% | 41.80% | 30.00% | 0.00% | 38.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 7.64% | 35.48% | 16.19% | -1.64% | -64.17% | 25.58% | -137.96% | -509.76% | 3.60% | 21.16% | 16.32% |
| Change in YoY Net Profit Growth (%) | 0.00% | 27.84% | -19.29% | -17.83% | -62.53% | 89.75% | -163.54% | -371.79% | 513.36% | 17.56% | -4.85% |
Daikaffil Chemicals India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | -14% |
| 3 Years: | -3% |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| TTM: | 51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 39% |
| 3 Years: | 90% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -9% |
| 3 Years: | -13% |
| Last Year: | -19% |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: December 4, 2025, 2:42 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
| Reserves | 4.43 | 5.22 | 6.60 | 18.38 | 19.54 | 19.46 | 19.96 | 19.58 | 18.52 | 16.12 | 4.54 | 2.85 | 1.90 |
| Borrowings | 2.37 | 1.89 | 0.71 | 0.00 | 0.00 | 0.00 | 0.71 | 0.56 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 9.38 | 6.83 | 5.56 | 3.35 | 4.72 | 2.64 | 3.54 | 2.36 | 1.81 | 1.35 | 1.61 | 5.93 | 7.50 |
| Total Liabilities | 22.18 | 19.94 | 18.87 | 27.73 | 30.26 | 28.10 | 30.21 | 28.50 | 26.70 | 23.47 | 12.15 | 14.78 | 15.40 |
| Fixed Assets | 5.51 | 5.37 | 5.34 | 15.14 | 14.69 | 14.16 | 14.01 | 12.98 | 13.92 | 12.43 | 1.63 | 1.96 | 2.25 |
| CWIP | 0.00 | 0.00 | 0.04 | 0.09 | 0.01 | 0.02 | 0.04 | 0.03 | 0.05 | 0.05 | 0.05 | 0.32 | 0.08 |
| Investments | 0.06 | 0.10 | 0.25 | 0.28 | 2.27 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.75 |
| Other Assets | 16.61 | 14.47 | 13.24 | 12.22 | 13.29 | 13.73 | 15.97 | 15.30 | 12.54 | 10.80 | 10.28 | 12.31 | 12.32 |
| Total Assets | 22.18 | 19.94 | 18.87 | 27.73 | 30.26 | 28.10 | 30.21 | 28.50 | 26.70 | 23.47 | 12.15 | 14.78 | 15.40 |
Below is a detailed analysis of the balance sheet data for Daikaffil Chemicals India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Reserves, as of Sep 2025, the value is 1.90 Cr.. The value appears to be declining and may need further review. It has decreased from 2.85 Cr. (Mar 2025) to 1.90 Cr., marking a decrease of 0.95 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 7.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.93 Cr. (Mar 2025) to 7.50 Cr., marking an increase of 1.57 Cr..
- For Total Liabilities, as of Sep 2025, the value is 15.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.78 Cr. (Mar 2025) to 15.40 Cr., marking an increase of 0.62 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2.25 Cr.. The value appears strong and on an upward trend. It has increased from 1.96 Cr. (Mar 2025) to 2.25 Cr., marking an increase of 0.29 Cr..
- For CWIP, as of Sep 2025, the value is 0.08 Cr.. The value appears to be declining and may need further review. It has decreased from 0.32 Cr. (Mar 2025) to 0.08 Cr., marking a decrease of 0.24 Cr..
- For Investments, as of Sep 2025, the value is 0.75 Cr.. The value appears strong and on an upward trend. It has increased from 0.19 Cr. (Mar 2025) to 0.75 Cr., marking an increase of 0.56 Cr..
- For Other Assets, as of Sep 2025, the value is 12.32 Cr.. The value appears strong and on an upward trend. It has increased from 12.31 Cr. (Mar 2025) to 12.32 Cr., marking an increase of 0.01 Cr..
- For Total Assets, as of Sep 2025, the value is 15.40 Cr.. The value appears strong and on an upward trend. It has increased from 14.78 Cr. (Mar 2025) to 15.40 Cr., marking an increase of 0.62 Cr..
Notably, the Reserves (1.90 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.60 | 1.10 | 2.46 | 4.67 | 3.29 | 1.80 | 1.13 | -0.39 | -2.41 | -1.91 | -2.25 | -1.79 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93.22 | 72.36 | 93.48 | 40.03 | 74.22 | 60.26 | 45.04 | 28.82 | 6.26 | 0.00 | 294.92 | |
| Inventory Days | 93.77 | 70.49 | 81.93 | 82.17 | 84.50 | 122.29 | 133.94 | 154.33 | 124.16 | 1,116.90 | 261.44 | |
| Days Payable | 132.45 | 85.28 | 69.49 | 34.20 | 80.69 | 39.27 | 80.53 | 59.90 | 7.49 | 21.90 | 341.10 | |
| Cash Conversion Cycle | 54.55 | 57.57 | 105.91 | 88.00 | 78.03 | 143.28 | 98.46 | 123.24 | 122.94 | 1,095.00 | 215.26 | |
| Working Capital Days | 46.17 | 47.71 | 83.63 | 76.89 | 93.25 | 113.14 | 73.37 | 99.89 | 108.25 | 4,956.02 | 279.35 | |
| ROCE % | 21.18% | 18.76% | 25.06% | 19.85% | 12.70% | 4.94% | 5.99% | -1.51% | -10.58% | -11.27% | -12.19% | -18.57% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.99 | 3.94 | 3.51 | 2.58 | 0.00 |
| Diluted EPS (Rs.) | 3.99 | 3.94 | 3.51 | 2.58 | 0.00 |
| Cash EPS (Rs.) | 5.56 | 6.55 | 4.18 | 3.26 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 42.84 | 40.92 | 20.89 | 18.57 | 0.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 42.84 | 40.92 | 21.30 | 18.99 | 0.00 |
| Revenue From Operations / Share (Rs.) | 38.02 | 44.06 | 45.74 | 57.54 | 0.00 |
| PBDIT / Share (Rs.) | 6.81 | 8.64 | 6.13 | 4.65 | 0.00 |
| PBIT / Share (Rs.) | 5.20 | 6.17 | 5.47 | 3.96 | 0.00 |
| PBT / Share (Rs.) | 5.17 | 6.14 | 5.31 | 3.61 | 0.00 |
| Net Profit / Share (Rs.) | 3.95 | 4.08 | 3.52 | 2.57 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 3.99 | 4.07 | 3.51 | 2.58 | 0.00 |
| PBDIT Margin (%) | 17.91 | 19.61 | 13.41 | 8.08 | 9.24 |
| PBIT Margin (%) | 13.68 | 14.01 | 11.96 | 6.87 | 7.44 |
| PBT Margin (%) | 13.58 | 13.92 | 11.61 | 6.27 | 6.54 |
| Net Profit Margin (%) | 10.39 | 9.26 | 7.69 | 4.46 | 4.02 |
| NP After MI And SOA Margin (%) | 10.48 | 9.24 | 7.66 | 4.49 | 4.21 |
| Return on Networth / Equity (%) | 9.37 | 10.02 | 17.03 | 14.13 | 0.00 |
| Return on Capital Employeed (%) | 11.66 | 14.30 | 24.61 | 20.13 | 0.00 |
| Return On Assets (%) | 7.86 | 8.76 | 11.04 | 7.69 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.17 | 0.00 |
| Asset Turnover Ratio (%) | 0.78 | 1.13 | 1.41 | 0.00 | 0.00 |
| Current Ratio (X) | 3.64 | 6.15 | 2.33 | 1.75 | 0.00 |
| Quick Ratio (X) | 2.79 | 4.42 | 1.63 | 1.22 | 0.00 |
| Inventory Turnover Ratio (X) | 4.00 | 3.91 | 3.90 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 51.29 | 29.57 | 28.51 | 30.94 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 36.54 | 18.41 | 23.98 | 24.38 | 0.00 |
| Earning Retention Ratio (%) | 48.71 | 70.43 | 71.49 | 69.06 | 0.00 |
| Cash Earning Retention Ratio (%) | 63.46 | 81.59 | 76.02 | 75.62 | 0.00 |
| Interest Coverage Ratio (X) | 188.00 | 227.77 | 38.19 | 13.38 | 8.22 |
| Interest Coverage Ratio (Post Tax) (X) | 110.03 | 108.62 | 22.92 | 8.48 | 5.44 |
| Enterprise Value (Cr.) | 30.57 | 33.78 | 15.30 | 14.48 | 0.00 |
| EV / Net Operating Revenue (X) | 1.34 | 1.28 | 0.55 | 0.41 | 0.00 |
| EV / EBITDA (X) | 7.48 | 6.51 | 4.16 | 5.18 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.50 | 1.45 | 0.57 | 0.40 | 0.00 |
| Retention Ratios (%) | 48.70 | 70.42 | 71.48 | 69.05 | 0.00 |
| Price / BV (X) | 1.34 | 1.57 | 1.27 | 1.29 | 0.00 |
| Price / Net Operating Revenue (X) | 1.50 | 1.45 | 0.57 | 0.40 | 0.00 |
| EarningsYield | 0.07 | 0.06 | 0.13 | 0.10 | 0.00 |
After reviewing the key financial ratios for Daikaffil Chemicals India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 18, the value is 3.99. This value is below the healthy minimum of 5. It has increased from 3.94 (Mar 17) to 3.99, marking an increase of 0.05.
- For Diluted EPS (Rs.), as of Mar 18, the value is 3.99. This value is below the healthy minimum of 5. It has increased from 3.94 (Mar 17) to 3.99, marking an increase of 0.05.
- For Cash EPS (Rs.), as of Mar 18, the value is 5.56. This value is within the healthy range. It has decreased from 6.55 (Mar 17) to 5.56, marking a decrease of 0.99.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 42.84. It has increased from 40.92 (Mar 17) to 42.84, marking an increase of 1.92.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 42.84. It has increased from 40.92 (Mar 17) to 42.84, marking an increase of 1.92.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 38.02. It has decreased from 44.06 (Mar 17) to 38.02, marking a decrease of 6.04.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 6.81. This value is within the healthy range. It has decreased from 8.64 (Mar 17) to 6.81, marking a decrease of 1.83.
- For PBIT / Share (Rs.), as of Mar 18, the value is 5.20. This value is within the healthy range. It has decreased from 6.17 (Mar 17) to 5.20, marking a decrease of 0.97.
- For PBT / Share (Rs.), as of Mar 18, the value is 5.17. This value is within the healthy range. It has decreased from 6.14 (Mar 17) to 5.17, marking a decrease of 0.97.
- For Net Profit / Share (Rs.), as of Mar 18, the value is 3.95. This value is within the healthy range. It has decreased from 4.08 (Mar 17) to 3.95, marking a decrease of 0.13.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 3.99. This value is within the healthy range. It has decreased from 4.07 (Mar 17) to 3.99, marking a decrease of 0.08.
- For PBDIT Margin (%), as of Mar 18, the value is 17.91. This value is within the healthy range. It has decreased from 19.61 (Mar 17) to 17.91, marking a decrease of 1.70.
- For PBIT Margin (%), as of Mar 18, the value is 13.68. This value is within the healthy range. It has decreased from 14.01 (Mar 17) to 13.68, marking a decrease of 0.33.
- For PBT Margin (%), as of Mar 18, the value is 13.58. This value is within the healthy range. It has decreased from 13.92 (Mar 17) to 13.58, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 18, the value is 10.39. This value exceeds the healthy maximum of 10. It has increased from 9.26 (Mar 17) to 10.39, marking an increase of 1.13.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is 10.48. This value is within the healthy range. It has increased from 9.24 (Mar 17) to 10.48, marking an increase of 1.24.
- For Return on Networth / Equity (%), as of Mar 18, the value is 9.37. This value is below the healthy minimum of 15. It has decreased from 10.02 (Mar 17) to 9.37, marking a decrease of 0.65.
- For Return on Capital Employeed (%), as of Mar 18, the value is 11.66. This value is within the healthy range. It has decreased from 14.30 (Mar 17) to 11.66, marking a decrease of 2.64.
- For Return On Assets (%), as of Mar 18, the value is 7.86. This value is within the healthy range. It has decreased from 8.76 (Mar 17) to 7.86, marking a decrease of 0.90.
- For Total Debt / Equity (X), as of Mar 18, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 0.78. It has decreased from 1.13 (Mar 17) to 0.78, marking a decrease of 0.35.
- For Current Ratio (X), as of Mar 18, the value is 3.64. This value exceeds the healthy maximum of 3. It has decreased from 6.15 (Mar 17) to 3.64, marking a decrease of 2.51.
- For Quick Ratio (X), as of Mar 18, the value is 2.79. This value exceeds the healthy maximum of 2. It has decreased from 4.42 (Mar 17) to 2.79, marking a decrease of 1.63.
- For Inventory Turnover Ratio (X), as of Mar 18, the value is 4.00. This value is within the healthy range. It has increased from 3.91 (Mar 17) to 4.00, marking an increase of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 18, the value is 51.29. This value exceeds the healthy maximum of 50. It has increased from 29.57 (Mar 17) to 51.29, marking an increase of 21.72.
- For Dividend Payout Ratio (CP) (%), as of Mar 18, the value is 36.54. This value is within the healthy range. It has increased from 18.41 (Mar 17) to 36.54, marking an increase of 18.13.
- For Earning Retention Ratio (%), as of Mar 18, the value is 48.71. This value is within the healthy range. It has decreased from 70.43 (Mar 17) to 48.71, marking a decrease of 21.72.
- For Cash Earning Retention Ratio (%), as of Mar 18, the value is 63.46. This value is within the healthy range. It has decreased from 81.59 (Mar 17) to 63.46, marking a decrease of 18.13.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 188.00. This value is within the healthy range. It has decreased from 227.77 (Mar 17) to 188.00, marking a decrease of 39.77.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 110.03. This value is within the healthy range. It has increased from 108.62 (Mar 17) to 110.03, marking an increase of 1.41.
- For Enterprise Value (Cr.), as of Mar 18, the value is 30.57. It has decreased from 33.78 (Mar 17) to 30.57, marking a decrease of 3.21.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 1.34. This value is within the healthy range. It has increased from 1.28 (Mar 17) to 1.34, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 18, the value is 7.48. This value is within the healthy range. It has increased from 6.51 (Mar 17) to 7.48, marking an increase of 0.97.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 17) to 1.50, marking an increase of 0.05.
- For Retention Ratios (%), as of Mar 18, the value is 48.70. This value is within the healthy range. It has decreased from 70.42 (Mar 17) to 48.70, marking a decrease of 21.72.
- For Price / BV (X), as of Mar 18, the value is 1.34. This value is within the healthy range. It has decreased from 1.57 (Mar 17) to 1.34, marking a decrease of 0.23.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 17) to 1.50, marking an increase of 0.05.
- For EarningsYield, as of Mar 18, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 17) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Daikaffil Chemicals India Ltd:
- Net Profit Margin: 10.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.66% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.37% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 110.03
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.79
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 92.81)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | Plot No. E/4, M.I.D.C, Tarapur, Palghar District Maharashtra 401506 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sadashiv K Shetty | Chairman |
| Mr. Raghuram K Shetty | Managing Director |
| Mr. Omprakash Singh | Independent Director |
| Mrs. Bhagavati Kalpesh Donga | Independent Director |
FAQ
What is the intrinsic value of Daikaffil Chemicals India Ltd?
Daikaffil Chemicals India Ltd's intrinsic value (as of 07 January 2026) is ₹30.05 which is 60.46% lower the current market price of ₹76.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹45.6 Cr. market cap, FY2025-2026 high/low of ₹281/68.5, reserves of ₹1.90 Cr, and liabilities of ₹15.40 Cr.
What is the Market Cap of Daikaffil Chemicals India Ltd?
The Market Cap of Daikaffil Chemicals India Ltd is 45.6 Cr..
What is the current Stock Price of Daikaffil Chemicals India Ltd as on 07 January 2026?
The current stock price of Daikaffil Chemicals India Ltd as on 07 January 2026 is ₹76.0.
What is the High / Low of Daikaffil Chemicals India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Daikaffil Chemicals India Ltd stocks is ₹281/68.5.
What is the Stock P/E of Daikaffil Chemicals India Ltd?
The Stock P/E of Daikaffil Chemicals India Ltd is .
What is the Book Value of Daikaffil Chemicals India Ltd?
The Book Value of Daikaffil Chemicals India Ltd is 13.2.
What is the Dividend Yield of Daikaffil Chemicals India Ltd?
The Dividend Yield of Daikaffil Chemicals India Ltd is 0.00 %.
What is the ROCE of Daikaffil Chemicals India Ltd?
The ROCE of Daikaffil Chemicals India Ltd is 18.6 %.
What is the ROE of Daikaffil Chemicals India Ltd?
The ROE of Daikaffil Chemicals India Ltd is 18.6 %.
What is the Face Value of Daikaffil Chemicals India Ltd?
The Face Value of Daikaffil Chemicals India Ltd is 10.0.